EBUS-TBNA for Lung Cancer

Phase-Based Progress Estimates
Toronto General Hospital, Toronto, CanadaLung CancerEBUS-TBNA - Procedure
All Sexes
What conditions do you have?

Study Summary

This trial reports that a less invasive but effective treatment, stereotactic body radiation therapy (SBRT), is well-tolerated for early stage lung cancer in medically inoperable patients.

Eligible Conditions
  • Lung Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 5 years

3 years
To test whether or not there is a difference in accuracy between CT/PET and the minimally invasive technique of EBUS-TBNA for mediastinal staging in patients with non-small cell lung cancer prior to stereotactic body radiotherapy (SBRT).
5 years
The treatment outcome (nodal recurrence rate) will be evaluated based on clinical chart review.

Trial Safety

Trial Design

1 Treatment Group

1 of 1

Experimental Treatment

150 Total Participants · 1 Treatment Group

Primary Treatment: EBUS-TBNA · No Placebo Group · N/A

Experimental Group · 1 Intervention: EBUS-TBNA · Intervention Types: Procedure
First Studied
Drug Approval Stage
How many patients have taken this drug
Completed Phase 4

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,386 Previous Clinical Trials
471,819 Total Patients Enrolled
Kazuhiro Yasufuku, MDPrincipal InvestigatorUHN
3 Previous Clinical Trials
431 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You do not want to have surgery.

Frequently Asked Questions

Are there any available slots for patients to join the clinical trial?

"Affirmative. The clinicaltrial.gov database reveals that this trial, which was initially launched on February 1st 2021, is currently recruiting. Approximately 150 participants need to be sourced from a single site." - Anonymous Online Contributor

Unverified Answer

What is the aggregate participation rate in this trial?

"Affirmative. Clinicaltrials.gov contains details confirming that this clinical trial is actively recruiting participants, beginning on February 1st 2013 and last updated on October 31st 2022. This experiment aims to enrol 150 volunteers from a single site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.